143 related articles for article (PubMed ID: 22004425)
1. Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study.
Tomoda T; Nouso K; Sakai A; Ouchida M; Kobayashi S; Miyahara K; Onishi H; Nakamura S; Yamamoto K; Shimizu K
J Gastroenterol Hepatol; 2012 Apr; 27(4):797-804. PubMed ID: 22004425
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
Abe H; Aida Y; Seki N; Sugita T; Tomita Y; Nagano T; Itagaki M; Sutoh S; Nagatsuma K; Itoh K; Matsuura T; Aizawa Y
J Gastroenterol Hepatol; 2015 Sep; 30(9):1376-83. PubMed ID: 25778454
[TBL] [Abstract][Full Text] [Related]
3. Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population.
Sakamoto T; Hara M; Higaki Y; Ichiba M; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Tanaka K
Int J Cancer; 2006 Mar; 118(6):1501-7. PubMed ID: 16187278
[TBL] [Abstract][Full Text] [Related]
4. Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk of primary hepatocellular carcinoma in a Chinese population.
Ding J; Li S; Wu J; Gao C; Zhou J; Cao H; Su PS; Liu Y; Zhou X; Chang J
Asian Pac J Cancer Prev; 2008; 9(1):31-5. PubMed ID: 18439068
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: risk and prognosis.
Zhu X; Chen MS; Tian LW; Li DP; Xu PL; Lin MC; Xie D; Kung HF
Int J Cancer; 2009 Sep; 125(6):1352-7. PubMed ID: 19533686
[TBL] [Abstract][Full Text] [Related]
6. An intronic single nucleotide polymorphism in the MUTYH gene is associated with increased risk for HCV-induced hepatocellular carcinoma.
Sakurada A; Miyanishi K; Tanaka S; Sato M; Sakamoto H; Kawano Y; Takada K; Nakabeppu Y; Kobune M; Kato J
Free Radic Biol Med; 2018 Dec; 129():88-96. PubMed ID: 30218772
[TBL] [Abstract][Full Text] [Related]
7. Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection.
Long J; Wang Y; Li M; Tong WM; Jia JD; Huang J
Oncol Rep; 2013 Jul; 30(1):119-24. PubMed ID: 23624687
[TBL] [Abstract][Full Text] [Related]
8. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
9. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Xia T; Li N; Zhang J; Yang Y; Cong W; Deng Q; Lan K; Zhou W
Protein Cell; 2013 Jan; 4(1):71-81. PubMed ID: 23292895
[TBL] [Abstract][Full Text] [Related]
11. The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population.
Balasus D; Way M; Fusilli C; Mazza T; Morgan MY; Cervello M; Giannitrapani L; Soresi M; Agliastro R; Vinciguerra M; Montalto G
Oncotarget; 2016 Dec; 7(52):86791-86802. PubMed ID: 27888630
[TBL] [Abstract][Full Text] [Related]
12. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive evaluation of single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Asian populations: A systematic review and network meta-analysis.
Zhang C; Ye Z; Zhang Z; Zheng J; Tang Y; Hou E; Huang Z; Meng L
Gene; 2020 Apr; 735():144365. PubMed ID: 31935498
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians.
Zhou D; Xiao L; Zhang Y; Xian J; Jiang J; Zong W; Huang Z; Yang Y
Tumour Biol; 2012 Jun; 33(3):841-6. PubMed ID: 22231434
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
16. A Non-Synonymous Single Nucleotide Polymorphism in the HJURP Gene Associated with Susceptibility to Hepatocellular Carcinoma among Chinese.
Huang W; Zhang H; Hao Y; Xu X; Zhai Y; Wang S; Li Y; Ma F; Li Y; Wang Z; Zhang Y; Zhang X; Liang R; Wei Z; Cui Y; Li Y; Yu X; Ji H; He F; Xie W; Zhou G
PLoS One; 2016; 11(2):e0148618. PubMed ID: 26863619
[TBL] [Abstract][Full Text] [Related]
17. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
18. Genetic biomarkers for hepatocellular cancer risk in a caucasian population.
De Mattia E; Cecchin E; Polesel J; Bignucolo A; Roncato R; Lupo F; Crovatto M; Buonadonna A; Tiribelli C; Toffoli G
World J Gastroenterol; 2017 Sep; 23(36):6674-6684. PubMed ID: 29085212
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs.
Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A
Cancer Chemother Pharmacol; 2018 Mar; 81(3):615-620. PubMed ID: 29356898
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
